Disruption of SynGAP-dopamine D1 receptor complexes alters actin and microtubule dynamics and impairs GABAergic interneuron migration.
Ping SuTerence K Y LaiFrankie H F LeeAndrew R AbelaPaul J FletcherFang LiuPublished in: Science signaling (2019)
Disruption of γ-aminobutyric acid (GABA)-ergic interneuron migration is implicated in various neurodevelopmental disorders, including autism spectrum disorder and schizophrenia. The dopamine D1 receptor (D1R) promotes GABAergic interneuron migration, which is disrupted in various neurological disorders, some of which are also associated with mutations in the gene encoding synaptic Ras-guanosine triphosphatase-activating protein (SynGAP). Here, we explored the mechanisms underlying these associations and their possible connection. In prenatal mouse brain tissue, we found a previously unknown interaction between the D1R and SynGAP. This D1R-SynGAP interaction facilitated D1R localization to the plasma membrane and promoted D1R-mediated downstream signaling pathways, including phosphorylation of protein kinase A and p38 mitogen-activated protein kinase. These effects were blocked by a peptide (TAT-D1Rpep) that disrupted the D1R-SynGAP interaction. Furthermore, disrupting this complex in mice during embryonic development resulted in pronounced and selective deficits in the tangential migration of GABAergic interneurons, possibly due to altered actin and microtubule dynamics. Our results provide insights into the molecular mechanisms regulating interneuron development and suggest that disruption of the D1R-SynGAP interaction may underlie SYNGAP1 mutation-related neurodevelopmental disorders.
Keyphrases
- protein kinase
- autism spectrum disorder
- signaling pathway
- traumatic brain injury
- bipolar disorder
- pregnant women
- resting state
- epithelial mesenchymal transition
- type diabetes
- oxidative stress
- attention deficit hyperactivity disorder
- copy number
- skeletal muscle
- cell migration
- small molecule
- wild type
- tyrosine kinase
- high fat diet induced
- amino acid
- blood brain barrier